Upcoming

Apply to Internal Competition // Limit: 2* // Tickets Available: 2

Basic through Pre-clinical Research Studies // Limit: 1 // Tickets Available: 1

Clinical through Public Health Research // Limit: 1 // Tickets Available: 1 

ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

Examples of basic through preclinical research studies (for nomination #1) include:

• Innovative mechanistic studies on fundamental or new aspects of biology
• Novel insights derived from data science using AI/Machine Learning
• Development of new technologies, devices, and/or experimental approaches
• Identification and validation of novel and unique therapeutic targets 

Examples of clinical through public health research (for nomination #2) include:

• Clinical experimental medicine studies
• Identification and validation of novel biomarkers
• Health services research
• Behavioral research
• Population epidemiology
• Health economics research
• Patient preference / Quality of Life
• Dissemination and implementation science

• Health Care system-based interventions

   

Initiator Award Eligibility

• Applicants must currently be in research training positions (i.e. post-doctoral fellowships, research fellowships) and can have no more than seven (7) years of training since their doctoral degree.
• Initiator award recipients cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
• Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full- time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.
• Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
• Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
• To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.
• Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission

Apply to Internal Competition // Limit: 1 // Tickets Available: 1 

Program Overview:
The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

Action Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility:
In accordance with Mr. Geneen’s directives, the Program supports smaller, mid-sized institutions. Each invited institution may only submit one application from a full-time faculty member. Junior faculty and those with less than $500,000 in direct costs funding at the time of application, are encouraged to apply. United States citizenship is not required.

Apply to Internal Competition // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one applicant for the Susan G. Komen Rising Star Researcher Award 2025 which recognizes innovative work, budding leadership and dedicated mentorship in breast cancer research and treatment.

For more information please contact: UACC-PreAward.

Purpose of Award:

This award will honor an investigator whose work has the potential to significantly impact the breast cancer field, who demonstrates strong leadership potential in the breast cancer community and who exhibits a strong commitment to trainee mentorship.

The Rising Star Researcher Award has become another marquee breast cancer research award for Susan G. Komen and complements the Brinker Awards established in 1992 to honor pioneers and distinguished investigators in basic science and clinical research.

The Rising Star Researcher Award will be given annually to:

• a breast cancer researcher from across the continuum of basic, translational, clinical, population health and implementation science research
• who is driving science that is having a substantial impact, expanding our understanding of breast cancer and/or improving breast cancer care and outcomes,
• is beginning to establish visibility and leadership in the field, beyond their scientific and/or clinical discoveries, and
• is demonstrating mentorship that is significantly impacting the education and professional development of research and/or clinical trainees.

Apply to Internal Competition // Limit: 3* // Tickets Available: 3

*The University of Arizona Cancer Center (UACC) can nominate up to three applicants (one per category) for the Susan G. Komen’s Brinker Awards for Scientific Distinction 2025 which recognizes pioneering work in breast cancer research and treatment. 

For more information please contact: UACC-PreAward.

Award Categories (Limit 1 Each) 

• The Brinker Award for Scientific Distinction in Basic Science will be presented to a basic science and/or translational researcher whose scientific discoveries or novel technologies have substantively impacted our understanding of the basic biology and intrinsic molecular processes driving breast cancer to improve breast cancer care.
• The Brinker Award for Scientific Distinction in Clinical Research will be presented to a clinical researcher who has advanced new approaches for prevention, detection, diagnosis and treatment that have paved the way for new clinical and therapeutic applications and/or practice changing, patient-focused care for breast cancer.
• The Brinker Award for Scientific Distinction in Population Science will be presented to a researcher who has made pivotal advances in implementing science, cancer care delivery, health services research, epidemiology and/or developed innovative evidence-based interventions to enhance breast cancer outcomes.

Apply to Internal Competition // Limit: 2* // Tickets Available: 2

The University of Arizona Cancer Center (UACC) can nominate can nominate up to two proposals: one Translational OR V Scholar nominee and one All-Star nominee (if eligible) for the V Foundation Pediatric Cancer Research Grant 2025.

For more information please contact: UACC-PreAward.

Eligibility

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US
• See additional criteria for each mechanism listed in corresponding RFA within the Supporting Documents section above.

Internal Competition Currently Under Review // Limit: 1 // Tickets Available: 1 

Eligibility
In fairness to other organizations seeking support, we ask that organizations submit only one concept application per round of funding.

Description
The Conservation, Food and Health Foundation seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East. 

For all fields of interest, please see the funding opportunity webpage.



 

Four tracks, see limits below: 

• Departmental/Division Transformation Track (DDTT) – No institutional limits on proposals
• Institutional Transformation Track (ITT) - Limit: 1 // Institutionally Coordinated
• Emerging Faculty Research Track (EFRT) – U of A is NOT ELIGIBLE
• HSI Program Resource Hubs (Hubs) – U of A is NOT (currently) ELIGIBLE  

HSI Initiatives must coordinate the submission for the Institutional Transformation Track or future Resource Hubs proposals. If you are interested in this funding opportunity, please contact Riley McIsaac.

Pre-proposals submitted to the internal competition are under review // Limit: 8* // Tickets Available: 8

* U of A may submit eight (8) concept papers: four (4) in medical sciences and four (4) in science & engineering.

Medical Research: Limit: 4 // Available: 4

Science and Engineering -  Limit: 4 // Available: 4

Program Description

Full sponsor guidelines https://www.wmkeck.org/research-overview/

Post selection as one of the pre-proposals, a concept review Zoom will be held with the W.M. Keck Foundation, RDS, and the UA Foundation in January will determine which one medical research and one science and engineering concept paper will be moved to a Phase 1 Submission.

The W.M. Keck Foundation Research Program uses a three-step process for this opportunity. The first step is a Concept paper. The next steps are by the foundation’s invitation. U of A review criteria reflect previous interactions with the W.M. Keck Foundation. Proposals should focus on basic, fundamental science with broad applications. Grants range from $1 million to $5 million and are typically $2 million or less, and more specifically in the $1.2 to $1.3 million range.

The proposed work should show a significant leap forward rather than an extension of existing work.

To be considered by Keck, applicants must have a statement expressing that the project is not a good fit due to risk (rather than technical or theoretical fit) or a decline from a federal program where the summary statement or individual reviews highlight the incredible novelty, but the high-risk nature that makes it difficult to fund at the federal level.

The Science and Engineering Research Program seeks to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have been awarded to support pioneering science and engineering research and the development of promising new technologies, instrumentation, or methodologies.

The Medical Research Program seeks to advance the frontiers of medicine to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have supported pioneering biological research, basic research, and the development of promising new technologies. The Keck Foundation does NOT fund work that is clinical, applied, or translational; treatment trials; or research for the sole purpose of drug development.

Both senior and early career investigators are encouraged to apply. Team approaches, including interdisciplinary teams, are encouraged.

Apply to Internal Competition  // Limit: 1 // Tickets Available: 1

This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to establish, or renew, an Alzheimer's Disease Research Center (ADRC).

NIA-designated ADRCs serve as a national resource for research on the nature of Alzheimer’s disease (AD) and AD-related dementias (ADRD) and the development of more effective approaches to prevention, diagnosis, care, and therapy. They create shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with other NIH-funded programs and investigators.